COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,822 Articles (22,968 medRxiv, 8,854 bioRxiv)

Most recent first Previous |  Page 1554: Articles 15531-15540  | Next

Covid-19 and Mental Health of Individuals with Different Personalities
Proto, E., Zhang, A.
10.1101/2021.05.24.21257581 — Posted: 2021-05-27
Multiplexed Detection of COVID-19 with Single-Molecule Technology
Furth, N., Shilo, S., Cohen, N., Erez, N., Fedyuk, V., Schrager, A. M., Weinberger, A., Dror, A. A., Zigron, A., Shehadeh, M., Sela, E., Srouji, S., Amit, S., Levy, I., Segal, E., Dahan, R., Jones, D., Doueck, D., Shema, E.
10.1101/2021.05.25.21257501 — Posted: 2021-05-27
Geographical and temporal distribution of SARS-CoV-2 globally: An attempt to correlate case fatality rate with the circulating dominant SARS-CoV-2 clades
Sarkar, R., Chawla-Sarkar, M., Majumdar, S., Lo, M., Chattopadhyay, S.
10.1101/2021.05.25.21257434 — Posted: 2021-05-27
Spread of endemic SARS-CoV-2 lineages in Russia
Klink, G., Safina, K. R., Garushyants, S. K., Moldovan, M., Nabieva, E., The CoRGI (Coronavirus Russian Genetic Initiative) Consortium, , Komissarov, A. B., Lioznov, D., Bazykin, G. A.
10.1101/2021.05.25.21257695 — Posted: 2021-05-27
Subacute SARS-CoV-2 replication can be controlled in the absence of CD8+ T cells in cynomolgus macaques
Nomura, T., Yamamoto, H., Nishizawa, M., Hau, T., Harada, S., Ishii, H., Seki, S., Nakamura-Hoshi, M., Okazaki, M., Daigen, S., Kawana-Tachikawa, A., Nagata, N., Iwata-Yoshikawa, N., Shiwa, N., Iida, S., Katano, H., Suzuki, T., Park, E.-S., Maeda, K., Suzaki, Y., Ami, Y., Matano, T.
10.1101/2021.05.26.445769 — Posted: 2021-05-26
Adenovirus transduction to express human ACE2 causes obesity-specific morbidity in mice, impeding studies on the effect of host nutritional status on SARS-CoV-2 pathogenesis.
Rai, P., Chuong, C., LeRoith, T., Smyth, J. W., Duggal, N. K., Weger-Lucarelli, J., Panov, J., Levi, M., Hall, K. K.
10.1101/2021.05.26.445786 — Posted: 2021-05-26
A modular molecular framework for quickly estimating the binding affinity of the spike protein of SARS-CoV-2 variants for ACE2, in presence of mutations at the spike receptor binding domain.
Tragni, V., Preziusi, F., Laera, L., Onofrio, A., Todisco, S., Volpicella, M., De Grassi, A., Pierri, C. L.
10.1101/2021.05.26.445422 — Posted: 2021-05-26
Variable Induction of Pro-inflammatory Cytokines by Commercial SARS CoV-2 Spike Protein Reagents: Potential Impacts of LPS on In Vitro Modeling and Pathogenic Mechanisms In Vivo
Ouyang, W., Xie, T., Fang, H., Gao, C., Stantchev, T., Clouse, K. A., Yuan, K., Ju, T., Frucht, D. M.
10.1101/2021.05.26.445843 — Posted: 2021-05-26
SARS-CoV-2 Nsp14 activates NF-κB signaling and induces IL-8 upregulation
Li, T.-W., Kenney, A. D., Liu, H., Fiches, G. N., Zhou, D., Biswas, A., Que, J., Santoso, N., Yount, J. S., Zhu, J.
10.1101/2021.05.26.445787 — Posted: 2021-05-26
Evidence of neutralizing antibodies against SARS-CoV-2 in domestic cats living with owners with a history of COVID-19 in Lima, Peru
Jara, L. M., Ferradas, C., Schiaffino, F., Sanchez-Carrion, C., Martinez, A., Ulloa, A., Isasi-Rivas, G., Montalvan, A., Sarmiento, L. G., Fernandez Diaz, M. C., Zimic, M.
10.1101/2021.05.26.445880 — Posted: 2021-05-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).